Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bbbe53b0329fc1a82458e2c4d8693f3 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-24069 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
filingDate |
2004-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee50b1b3347f257a076463daece2fcb4 |
publicationDate |
2006-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
GB-2419817-A |
titleOfInvention |
Treatment of cardiac fibrillation disorders |
abstract |
The instant invention relates to the use of a pre-synaptic neuromuscular blocking substance for preparing a medicament intended to treat or prevent heart fibrillation disorders. Preferably, the pre-synaptic neuromuscular blocking substance will be a botulinum toxin. Preferably also, the heart fibrillation disorder to be treated or prevented will be atrial fibrillation. |
priorityDate |
2004-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |